Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer.,Annals of Laboratory Medicine

当前位置： X-MOL 学术 › Ann. Lab. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer.
Annals of Laboratory Medicine ( IF 4.0 ) Pub Date : 2021-10-13 , DOI: 10.3343/alm.2022.42.2.249
Mina Hur ₁ , Mikyoung Park ₂ , Hee-Won Moon ₁ , Won Hyeok Choe ₃ , Chae Hoon Lee ₂

Affiliation

Non-invasive clinical algorithms for the detection of liver fibrosis (LF) can reduce the need for liver biopsy (LB). We explored the implementation of two serum biomarkers, enhanced liver fibrosis (ELF) and Mac-2 binding protein glycosylation isomer (M2BPGi), in clinical algorithms for LF in chronic hepatitis B (CHB) patients.

中文翻译：

慢性乙型肝炎患者肝纤维化减少肝活检需求的非侵入性临床算法比较：增强型肝纤维化和 Mac-2 结合蛋白糖基化异构体的应用。

用于检测肝纤维化（LF）的非侵入性临床算法可以减少肝活检（LB）的需要。我们探索了两种血清生物标志物，即增强型肝纤维化 (ELF) 和 Mac-2 结合蛋白糖基化异构体 (M2BPGi) 在慢性乙型肝炎 (CHB) 患者 LF 临床算法中的应用。

更新日期：2021-10-13

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11